PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayIn a clinical report published in Molecular Cytogenetics, medical researchers have documented the first detailed clinical and phenotypic characterization of an infant harboring a rare homozygous splice-site variant in the UBE3B gene, confirming its link to Kaufman oculocerebrofacial syndrome. The investigation evaluated a 12-month-old Jordanian girl born to consanguineous parents who presented with microcephaly, hypotonia, global developmental delay, and failure to thrive. While the specific genomic alteration had previously been logged as pathogenic in the ClinVar database, earlier records lacked corresponding phenotypic descriptions, leaving clinicians without published documentation of its clinical manifestations.
Kaufman oculocerebrofacial syndrome is an exceptionally rare autosomal recessive condition first identified in four siblings by Kaufman and colleagues in 1971, with biallelic loss-of-function variants in UBE3B established as the underlying molecular etiology in 2012. The UBE3B gene encodes an E3 ubiquitin ligase that plays a regulatory role in proteasomal degradation and neurodevelopmental pathways. Deleterious variants within this gene—including nonsense, frameshift, and canonical splice-site mutations—impair normal protein synthesis and enzymatic activity, producing widespread neurodevelopmental and physical anomalies.
The established phenotypic spectrum of Kaufman oculocerebrofacial syndrome encompasses distinctive facial dysmorphism, cognitive impairment, and multiorgan involvement spanning the neurological, ocular, cardiovascular, skeletal, and renal systems. Characteristic craniofacial hallmarks typically include microcephaly, blepharophimosis, ptosis, hypertelorism, short palpebral fissures, low-set ears accompanied by preauricular skin tags, and micrognathia. Study authors noted that although molecular discoveries across diverse cohorts have continually broadened the recognized spectrum of the disorder, cases may remain underrecognized in geographical regions with elevated rates of consanguinity.
The patient described in the report was the fourth child born to healthy consanguineous parents following delivery by cesarean section at 36 weeks of gestation. Mild fetal growth restriction was documented at delivery, with a birth weight of 2.4 kilograms, corresponding to a z-score of minus 1.0, and an occipitofrontal head circumference of 30 centimeters, reflecting a z-score of minus 1.7. Apgar scores were recorded as 5 at one minute, 6 at five minutes, and 6 at ten minutes, prompting immediate admission to a neonatal intensive care unit for dysmorphic features and respiratory distress.
The family medical history highlighted additional complications within a consanguineous background, including two older living siblings who remain healthy at ages 11 and 7. However, an earlier pregnancy resulted in a female infant delivered prematurely at 33 weeks of gestation who died at one week of life from respiratory distress syndrome. Furthermore, an extended paternal family evaluation identified an infant born to the father’s sister who died at seven days of age from an unspecified central nervous system disorder, raising clinical suspicion for inherited recessive conditions.
Upon physical examination at 12 months, the index patient exhibited a classic constellation of dysmorphic characteristics, including microcephaly, hypertelorism, a high forehead, epicanthal folds, a broad nasal bridge, a short philtrum, micrognathia, low-set ears, periauricular skin tags, and widely spaced nipples. Cutaneous examination identified a solitary café-au-lait macule located beneath the right axilla, while neurological assessment verified generalized hypotonia alongside preserved deep tendon reflexes. The anterior fontanelle remained open and appropriately sized, and examiners observed no limb hyperlaxity or skeletal malformations.
Systemic medical evaluations identified cardiac involvement presenting as mild basal septal hypertrophy on echocardiography, an atypical finding that suggests variable expressivity of cardiovascular features in affected individuals. Brain magnetic resonance imaging conducted during the neonatal period revealed no structural malformations, and subsequent renal ultrasonography, audiological screenings, and ophthalmologic evaluations—including fundoscopic examination and red reflex testing—demonstrated normal results. Initial endocrine testing revealed low free thyroxine alongside normal thyroid-stimulating hormone levels, though follow-up testing at three months of age showed spontaneous normalization without medication.
Throughout early infancy, developmental tracking confirmed moderate global delay alongside failure to thrive, despite the infant displaying normal physiological swallowing and feeding mechanics. The patient attained head control at approximately 5 months of age, rolled over at 7 months, achieved unsupported sitting at 11 months, smiled socially at 3 months, and developed babbling at 9 months without acquiring expressive words. Fine motor skills showed marked limitation in object manipulation and pincer grasp, and caloric insufficiency stemming from elevated metabolic demands prompted the implementation of high-caloric nutritional supplementation.
To establish a definitive diagnosis, genomic DNA extracted from whole blood was analyzed via whole-exome sequencing on an Illumina NovaSeq X platform utilizing customized target-enrichment panels. The sequencing process generated 10.4 billion bases and yielded an average coverage depth of 152.81-fold across 34.2 million target bases, achieving greater than twenty-fold coverage across 99.4 percent of regions. Bioinformatic processing through GATK, Manta, and variant annotation pipelines resolved single-nucleotide and structural variants against clinical sequencing databases.
The genetic analysis identified a homozygous splice-site mutation, designated c.1741+2T>C, which disrupts the invariant donor splice site in UBE3B and yielded an in silico SpliceAI prediction score of 0.97. The mutation was classified as pathogenic under ACMG/AMP and ClinGen criteria, supported by absent homozygotes in the gnomAD population database and concordant disease mechanisms observed in previous functional studies. The authors concluded that early genomic sequencing is essential for clarifying rare syndromic presentations in consanguineous settings, providing families with precise prognostic information and reproductive guidance.
To establish the pathogenicity of the c.1741+2T>C mutation, the investigating clinicians evaluated the alteration against the 2024 ClinGen Sequence Variant Interpretation criteria and American College of Medical Genetics guidelines, assigning specific evidence codes to validate its disease-causing status. The disruption of the invariant plus two donor splice site fulfilled the very strong PVS1 criterion, substantiated by the high in silico SpliceAI prediction score of 0.97 and by experimental precedent from Basel-Vanagaite and colleagues demonstrating exon-skipping in comparable splice-site disruptions. The moderate PM2 criterion was satisfied by examining population-level sequencing in gnomAD version 4.1.0, which confirmed the variant’s extreme scarcity and the complete absence of homozygous carriers. Additionally, the classification met the supporting PS4 criterion through documented occurrence of this identical splice alteration in an unrelated patient exhibiting a concordant syndromic presentation, contextualizing the initial ClinVar entry that had lacked accompanying phenotypic records.
The clinical authors, Abedulrhman S. Abdelfattah and Mohammad Abu Saleh, explored how the nature of UBE3B molecular lesions correlates with symptom severity in Kaufman oculocerebrofacial syndrome. Their analysis highlighted that biallelic loss-of-function variants, including nonsense mutations, frameshift insertions or deletions, and canonical splice-site disruptions such as c.1741+2T>C, consistently drive the classical syndrome phenotype. In contrast, researchers noted that hypomorphic or missense alterations have occasionally been linked to variable expressivity or milder clinical features in the broader medical literature, though such distinctions remain under active scientific investigation. The Jordanian infant presented with clinical signs that matched the full, classic loss-of-function disease presentation rather than an attenuated variant course.
The study contextualized the child’s manifestations against previous patient cohorts described by Yilmaz and colleagues in 2017 and 2018, Zaki and colleagues in 2020, and the landmark 2012 report by Basel-Vanagaite and colleagues. Core physical characteristics observed in the infant, including microcephaly, low-set ears, preauricular skin tags, micrognathia, hypotonia, and global developmental delay, closely mirrored the clinical findings recorded across those published cohorts. However, the presence of mild basal septal hypertrophy stood out as a relatively uncommon finding that had not been frequently reported in earlier case series. The researchers emphasized that this isolated septal thickening expands the recognized scope of cardiac involvement in Kaufman oculocerebrofacial syndrome, illustrating that cardiovascular manifestations can exhibit marked heterogeneity across affected patients rather than conforming to a uniform cardiac presentation.
The authors evaluated the wider clinical implications of parental consanguinity and the family’s history of neonatal loss, noting that such pedigrees provide valuable insight into the variable expressivity of recessive disorders. While extended family members remained healthy without documented congenital anomalies, the occurrence of early neonatal mortality in an infant sibling delivered at 33 weeks and a paternal cousin dying from an unspecified central nervous system illness raised important diagnostic considerations. The authors pointed out that individuals sharing identical underlying pathogenic mutations may manifest distinct degrees of severity and variable organ system involvement.
Following inpatient stabilization, the patient’s long-term clinical care required ongoing coordination across genetics, pediatric neurology, endocrinology, and cardiology services to monitor developmental progress and cardiac status. Clinical evaluations helped delineate the negative boundaries of the child’s phenotype, confirming normal bowel and urinary elimination, intact audiology, preserved deep tendon reflexes, and an absence of limb anomalies such as joint hyperlaxity or elongated digits, while serum lipid profiling was not assessed. Written informed consent was secured from the child’s legal guardian authorizing the publication of the case description and accompanying clinical photographs, with all generated diagnostic findings incorporated into the published report. The authors concluded that early whole-exome sequencing provides indispensable utility in evaluating syndromic infants from consanguineous populations, ensuring that rare splice-site mutations receive robust phenotypic documentation to optimize clinical surveillance, nutritional management, and reproductive genetic counseling.
Subject of Research: Clinical and molecular characterization of Kaufman oculocerebrofacial syndrome
Article Title: Kaufman oculocerebrofacial syndrome: case report of a UBE3B splice site variant and clinical overview of reported patients
Article References: Abdelfattah, A. S., & Saleh, M. A. (2025). Kaufman oculocerebrofacial syndrome: case report of a UBE3B splice site variant and clinical overview of reported patients. Molecular Cytogenetics, 19(1), Article 1. https://doi.org/10.1186/s13039-025-00742-3
Image Credits: AI Generated
DOI: 10.1186/s13039-025-00742-3
Keywords: Kaufman oculocerebrofacial syndrome, UBE3B, c.1741+2T>C, splice-site variant, whole-exome sequencing, microcephaly, hypotonia, developmental delay, basal septal hypertrophy, consanguinity, failure to thrive, ACMG/AMP criteria, SpliceAI, gnomAD, E3 ubiquitin ligase, preauricular tags, pediatric genetics


2 hours ago
7




















English (US) ·
French (CA) ·